ISSN: 2228-5881 eISSN: 2251-7308

Adv Pharm Bull. 2020;10(2): 166-183. doi: 10.34172/apb.2020.022

PMID: 32373486 PMCID: PMC7191229

Review Article

Cyclodextrin Based Nanoparticles for Drug Delivery and Theranostics

Dipak Dilip Gadade ^1,2 * , Sanjay Sudhakar Pekamwar ²

Cited by CrossRef: 93

1- Otieno E, Huang Y, Li N, Li T, Wang M, Qiu X, Xiao X. Utilization of superparamagnetic iron oxide nanoparticles (SPIONs) as a vector for drug delivery. Appl Nanosci. 2023;13(9):6191 [Crossref]

2- Alavi M, Varma R. Antibacterial and wound healing activities of silver nanoparticles embedded in cellulose compared to other polysaccharides and protein polymers. Cellulose. 2021;28(13):8295 [Crossref]

3- Veetil V, Rajeeve A, G.P S, Manish Kumar K, Bhagiyalakshmi M, Vinoba M, Yamuna R. β-Cyclodextrin capped ZnS nanoparticles for CER-assisted colorimetric and spectrophotometric detection of Pb2⁺, Cu2⁺, and Hg2⁺ in an aqueous solution. Heliyon. 2023;9(11):e21850 [Crossref]

4- Payamifar S, Foroozandeh A, Pourmadadi M, Abdouss M. Cyclodextrin nanocarriers in Coordination Chemistry: Enhancing encapsulation and targeted delivery of 5-Fluorouracil for cancer treatment. Results in Chemistry. 2024;12:101878 [Crossref]

5- Ghitman J, Voicu S. Controlled drug delivery mediated by cyclodextrin-based supramolecular self-assembled carriers: From design to clinical performances. Carbohydrate Polymer Technologies and Applications. 2023;5:100266 [Crossref]

6- Bognanni N, Viale M, Distefano A, Tosto R, Bertola N, Loiacono F, Ponassi M, Spinelli D, Pappalardo G, Vecchio G. Cyclodextrin Polymers as Delivery Systems for Targeted Anti-Cancer Chemotherapy. Molecules. 2021;26(19):6046 [Crossref]

7- Arcot Y, Mu M, Iepure M, Yodong R, Zhou W, Min Y, Cisneros-Zevallos L, Akbulut M. Influence of nanopesticide surface chemistry on adsorption to plant cuticle and wax layer: The role of zeta potential and wetting. Surfaces and Interfaces. 2024;54:105190 [Crossref]

8- Yilmaz A, Sahiner N. Super porous α‐, β‐, γ‐cyclodextrin cryogels with high active agent loading and controllable release profiles. J of Applied Polymer Sci. 2024;141(3) [Crossref]

9- Yakkala P, Penumallu N, Shafi S, Kamal A. Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents. Pharmaceuticals. 2023;16(10):1456 [Crossref]

10- Haegebaert R, Kempers M, Ceelen W, Lentacker I, Remaut K. Nanoparticle mediated targeting of toll-like receptors to treat colorectal cancer. European Journal of Pharmaceutics and Biopharmaceutics. 2022;172:16 [Crossref]

11- Grigoryan I, Adelyanov A, Parkhaeva A, Khomutov G, Simonenko E, Mironova A, Pigareva V, Sybachin A. Features of the Formation of Complexes of $${\beta}$$-Carboxymethyl Cyclodextrins on the Surface of Lipid Monolayers. Moscow Univ Phys. 2024;79(5):621 [Crossref]

12- Rivero-Barbarroja G, Benito J, Ortiz Mellet C, García Fernández J. Cyclodextrin-Based Functional Glyconanomaterials. Nanomaterials. 2020;10(12):2517 [Crossref]

13- Tomou E, Papakyriakopoulou P, Saitani E, Valsami G, Pippa N, Skaltsa H. Recent Advances in Nanoformulations for Quercetin Delivery. Pharmaceutics. 2023;15(6):1656 [Crossref]

14- Arya P, Raghav N. In-vitro studies of Curcumin-β-cyclodextrin inclusion complex as sustained release system. Journal of Molecular Structure. 2021;1228:129774 [Crossref]

15- Lu Q. Bioresponsive and multifunctional cyclodextrin-based non-viral nanocomplexes in cancer therapy: Building foundations for gene and drug delivery, immunotherapy and bioimaging. Environmental Research. 2023;234:116507 [Crossref]

16- Real D, Bolaños K, Priotti J, Yutronic N, Kogan M, Sierpe R, Donoso-González O. Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability. Pharmaceutics. 2021;13(12):2131 [Crossref]

17- Pawar C, Rajendra Prasad N, Yadav P, Muthu Vijayan Enoch I, Manikantan V, Dey B, Baruah P. Enhanced delivery of quercetin and doxorubicin using β-cyclodextrin polymer to overcome P-glycoprotein mediated multidrug resistance. International Journal of Pharmaceutics. 2023;635:122763 [Crossref]

18- Daya T, Breytenbach A, Gu L, Kaur M. Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2025;1870(2):159578 [Crossref]

19- Guleria A, Aishwarya J, Kunwar A, Neogy S, Debnath A, Rath M, Adhikari S, Tyagi A. Solvated electron-induced synthesis of cyclodextrin-coated Pd nanoparticles: mechanistic, catalytic, and anticancer studies. Dalton Trans. 2023;52(4):1036 [Crossref]

20- Rajamohan R, Ashokkumar S, Lee Y. Environmental free synthesis of biologically active Cu2O nanoparticles for the cytotoxicity. Journal of Molecular Structure. 2023;1271:134081 [Crossref]

21- Waqar M, Mubarak N, Khan A, Ahmad S, Zaib M, Kanwal U, Khan I, Ayesha M, Mughal M, Fahad M. Innovation in nanomedicine: nanocarriers for central nervous system disorders management. International Journal of Polymeric Materials and Polymeric Biomaterials. 2024;:1 [Crossref]

22- Tarannum N, Kumar D, Kumar N. β‐Cyclodextrin‐Based Nanocomposite Derivatives: State of the Art in Synthesis, Characterization and Application in Molecular Recognition. ChemistrySelect. 2022;7(22) [Crossref]

23- Pant A, Sharma G, Saini S, Kaur G, Jain A, Thakur A, Singh B. QbD-driven development of phospholipid-embedded lipidic nanocarriers of raloxifene: extensive in vitro and in vivo evaluation studies. Drug Deliv and Transl Res. 2024;14(3):730 [Crossref]

24- Pilch J, Kowalik P, Kowalczyk A, Bujak P, Kasprzak A, Paluszkiewicz E, Augustin E, Nowicka A. Foliate-Targeting Quantum Dots-β-Cyclodextrin Nanocarrier for Efficient Delivery of Unsymmetrical Bisacridines to Lung and Prostate Cancer Cells. IJMS. 2022;23(3):1261 [Crossref]

25- Jampilek J, Kralova K. Advances in Nanostructures for Antimicrobial Therapy. Materials. 2022;15(7):2388 [Crossref]

26- Ji X, Zou Y, Lei H, Bi Y, Yang R, Tang J, Jin Q. Advances in Cyclodextrins and Their Derivatives in Nano-Delivery Systems. Pharmaceutics. 2024;16(8):1054 [Crossref]

27- Abu Koush A, Popa E, Pricop D, Nita L, Foia C, Pauna A, Buca B, Pavel L, Mititelu-Tartau L. Enhanced Stability and In Vitro Biocompatibility of Chitosan-Coated Lipid Vesicles for Indomethacin Delivery. Pharmaceutics. 2024;16(12):1574 [Crossref]

28- Jackson B, Cluck D, Henao-Martínez A, Chastain D. Kimyrsa and Orbactiv – A Tale of Two Formulations. DDDT. 2023;Volume 17:737 [Crossref]

29- Matuwana D, Hong E, Huang S, Xu X, Jang G, Xiao R, Rao S, Wang Q. Near-infrared activated liposomes for neuroprotection in glaucoma. J Mater Chem B. 2024;12(42):10902 [Crossref]

30- Meylina L, Muchtaridi M, Joni I, Mohammed A, Wathoni N. Nanoformulations of α-Mangostin for Cancer Drug Delivery System. Pharmaceutics. 2021;13(12):1993 [Crossref]

31- Singh P, Mahar R. Cyclodextrin in drug delivery: Exploring scaffolds, properties, and cutting-edge applications. International Journal of Pharmaceutics. 2024;662:124485 [Crossref]

32- Heidari Nia M, Ashkar S, Munguia-Lopez J, Kinsella J, van de Ven T. Hairy Nanocellulose-Based Supramolecular Architectures for Sustained Drug Release. Biomacromolecules. 2023;24(5):2100 [Crossref]

33- Soe H, Loftsson T, Jansook P. The application of cyclodextrins in drug solubilization and stabilization of nanoparticles for drug delivery and biomedical applications. International Journal of Pharmaceutics. 2024;666:124787 [Crossref]

34- Christoforides E, Andreou A, Papaioannou A, Bethanis K. Structural Studies of Piperine Inclusion Complexes in Native and Derivative β-Cyclodextrins. Biomolecules. 2022;12(12):1762 [Crossref]

35- Gayathri K, Bhaskaran M, Selvam C, Thilagavathi R. Nano formulation approaches for curcumin delivery- a review. Journal of Drug Delivery Science and Technology. 2023;82:104326 [Crossref]

36- Li X, Liu J, Qiu N. Cyclodextrin-Based Polymeric Drug Delivery Systems for Cancer Therapy. Polymers. 2023;15(6):1400 [Crossref]

37- Gandhi S, Shende P. Cyclodextrins-modified metallic nanoparticles for effective cancer therapy. Journal of Controlled Release. 2021;339:41 [Crossref]

38- Bohloli A, Asli M, Moniri E, Gh A. Modification of WS2 nanosheets with beta-cyclodextrone and N-isopropylacrylamide polymers for tamoxifen adsorption and investigation of in vitro drug release. Res Chem Intermed. 2021;47(5):1955 [Crossref]

39- Maddiboyina B, Roy H, Ramaiah M, Sarvesh C, Kosuru S, Nakkala R, Nayak B. Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs. Bull Natl Res Cent. 2023;47(1) [Crossref]

40- Reichardt S, Amouret A, Muzzi C, Vettorazzi S, Tuckermann J, Lühder F, Reichardt H. The Role of Glucocorticoids in Inflammatory Diseases. Cells. 2021;10(11):2921 [Crossref]

41- Mane N, Rane B, Jain A. Advances in Nanosuspension Technology: Current Trends and Future Horizons. 2024;16(4):574 [Crossref]

42- Ansari M, Ravan Avard E, Sharififar F, Mohamadi N. Synthesis and characterization of nano-biopolymer carriers loaded with clove ( Syzygium aromaticum L.) extract as an anticancer agent: an in vitro study . Journal of Biomaterials Science, Polymer Edition. 2024;35(15):2363 [Crossref]

43- Soni S, D'Elia A, Alsasa A, Cho S, Tylek T, O'Brien E, Whitaker R, Spiller K, Rodell C. Sustained release of drug-loaded nanoparticles from injectable hydrogels enables long-term control of macrophage phenotype. Biomater Sci. 2022;10(24):6951 [Crossref]

44- Wong K, Lu A, Chen X, Yang Z. Natural Ingredient-Based Polymeric Nanoparticles for Cancer Treatment. Molecules. 2020;25(16):3620 [Crossref]

45- Huanbutta K, Suwanpitak K, Weeranoppanant N, Sriamornsak P, Garg K, Sharma S, Singh I, Sangnim T. Continuous flow synthesis: A promising platform for the future of nanoparticle-based drug delivery. Journal of Drug Delivery Science and Technology. 2024;91:105265 [Crossref]

46- Migone C, Grassiri B, Vizzoni L, Fabiano A, Ferro B, Zambito Y, Piras A. Aerosol of Enoximone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex, Biopharmaceutical Evidence for ARDS Applicability. Pharmaceutics. 2024;16(9):1221 [Crossref]

47- Payamifar S, Foroozandeh A, Pourmadadi M, Abdouss M, Hasanzadeh M. Cyclodextrin-based nanocarriers as promising scaffolds for overcoming challenges of doxorubicin delivery in cancer chemotherapy. Carbohydrate Polymer Technologies and Applications. 2025;:100677 [Crossref]

48- Rani D, Sharma V, Chauhan B, Singh R. RECENT ADVANCES IN NANOTECHNOLOGY - BASED DRUG DELIVERY SYSTEMS FOR DELIVERY OF PHYTOCONSTITUENTS WITH SPECIAL EMPHASIS ON PSORIASIS MANAGEMENT. IND DRU. 2024;61(04):7 [Crossref]

49- Bognanni N, Viale M, La Piana L, Strano S, Gangemi R, Lombardo C, Cambria M, Vecchio G. Hyaluronan-Cyclodextrin Conjugates as Doxorubicin Delivery Systems. Pharmaceutics. 2023;15(2):374 [Crossref]

50- Parvez S, Yadagiri G, Arora K, Javaid A, Kushwaha A, Singh O, Sundar S, Mudavath S. Coalition of Biological Agent (Melatonin) With Chemotherapeutic Agent (Amphotericin B) for Combating Visceral Leishmaniasis via Oral Administration of Modified Solid Lipid Nanoparticles. ACS Biomater Sci Eng. 2023;9(6):2902 [Crossref]

51- Varan G, Akkın S, Demirtürk N, Benito J, Bilensoy E. Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver. Journal of Drug Targeting. 2021;29(4):439 [Crossref]

52- Dali P, Shende P. Inclusion complex of cyclodextrin with ergotamine and evaluation of cyclodextrin-based nanosponges. J Incl Phenom Macrocycl Chem. 2022;102(7-8):669 [Crossref]

53- Mandani S, Rezaei B, Ensafi A, Sabzalian M. Development of a new simple spectroscopic determination coupled acid-motivated delivery system based on fluorescence turn-off MSNs@MPA-ZnS QDs for infection. Microporous and Mesoporous Materials. 2021;317:110971 [Crossref]

54- Li T, Guo R, Zong Q, Ling G. Application of molecular docking in elaborating molecular mechanisms and interactions of supramolecular cyclodextrin. Carbohydrate Polymers. 2022;276:118644 [Crossref]

55- Mukherjee S, Mazumder P, Joshi M, Joshi C, Dalvi S, Kumar M. Biomedical application, drug delivery and metabolic pathway of antiviral nanotherapeutics for combating viral pandemic: A review. Environmental Research. 2020;191:110119 [Crossref]

56- Khajir S, Karimzadeh Z, Khoubnasabjafari M, Jouyban-Gharamaleki V, Rahimpour E, Jouyban A. A Rayleigh light scattering technique based on β- cyclodextrin modified gold nanoparticles for phenytoin determination in exhaled breath condensate. Journal of Pharmaceutical and Biomedical Analysis. 2023;223:115141 [Crossref]

57- Salari A, Roshanaei K, Rasoulian B, Fard J. Carvacrol loaded beta cyclodextrin-alginate-chitosan based nanoflowers attenuates renal toxicity induced by malathion and parathion: A comparative toxicity. Pesticide Biochemistry and Physiology. 2021;172:104747 [Crossref]

58- Kurul F, Turkmen H, Cetin A, Topkaya S. Nanomedicine: How nanomaterials are transforming drug delivery, bio-imaging, and diagnosis. Next Nanotechnology. 2025;7:100129 [Crossref]

59- Elmoghayer M, Saleh N, Abu Hashim I. Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study. Drug Deliv and Transl Res. 2024;14(4):895 [Crossref]

60- Neaz S, Alam M, Imran A. Advancements in cyclodextrin-based controlled drug delivery: Insights into pharmacokinetic and pharmacodynamic profiles. Heliyon. 2024;10(21):e39917 [Crossref]

61- Muruganantham S, Krishnaswami V, Alagarsamy S, Kandasamy R. Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis. CDT. 2021;22(4):399 [Crossref]

62- Mulenga G, Alahmed T, Sami F, Majeed S, Ali M, Le J, Rhu C, Nair R, Hasan N, Ansari M. QbD Assisted Systematic Review for Optimizing the Selection of PVP as a Ternary Substance in Enhancing the Complexation Efficiency of Cyclodextrins: a Pilot Study. AAPS PharmSciTech. 2024;25(5) [Crossref]

63- Kaliyaperumal V, Alharbi R, Rajendhran H, Gopal D, Al-Otibi F. Beta-cyclodextrin–Phyllanthus emblica emulsion for zinc oxide nanoparticles: Characteristics and photocatalysis. 2024;13(1) [Crossref]

64- Choi S, Talmon G, Britigan B, Narayanasamy P. Nanoparticulate β-Cyclodextrin with Gallium Tetraphenylporphyrin Demonstrates in Vitro and in Vivo Antimicrobial Efficacy against Mycobacteroides abscessus and Mycobacterium avium. ACS Infect Dis. 2021;7(8):2299 [Crossref]

65- Singh D, Sharma Y, Dheer D, Shankar R. Stimuli responsiveness of recent biomacromolecular systems (concept to market): A review. International Journal of Biological Macromolecules. 2024;261:129901 [Crossref]

66- Chenglin Z, Jihao S, Hongxia Z, Yang L, Xu Z. Suger-coated pillararenes for drug delivery applications. E3S Web Conf. 2020;185:03048 [Crossref]

67- Pestovsky Y, Srichana T. Formation of Aggregate-Free Gold Nanoparticles in the Cyclodextrin-Tetrachloroaurate System Follows Finke–Watzky Kinetics. Nanomaterials. 2022;12(4):583 [Crossref]

68- Barfar A, Alizadeh H, Masoomzadeh S, Javadzadeh Y. Oral Insulin Delivery: A Review on Recent Advancements and Novel Strategies. CDD. 2024;21(6):887 [Crossref]

69- Raguzin E, Yudin M, Glushenko D, Vengerovich N, Raguzina O, Pechurina T, Shefer T, Ivanov I. Analysis and Evaluation of Modern Approaches to Development of Medical Drugs Using Micro- and Nanotechnologies. IP Pavlov Russian Medical Biological Herald. 2022;30(3):397 [Crossref]

70- Holzinger M, Buzzetti P, Cosnier S. Polymers and nano-objects, a rational combination for developing health monitoring biosensors. Sensors and Actuators B: Chemical. 2021;348:130700 [Crossref]

71- Saxena S, Lis M. Native Cyclodextrin-Based Metal–Organic Frameworks (MOFs): Synthesis, Characterization, and Potential Applications in Food Industry. Molecules. 2025;30(2):293 [Crossref]

72- Singh N, Mudassir M, Ansari S, Chosdol K, Sinha S, Chattopadhyay P. Poly(lactic-co-glycolic) Acid Nanoparticles Localize in Vesicles After Diffusing into Cells and are Retained by Intracellular Traffic Modulators. Nanomedicine (Lond). 2023;18(26):1907 [Crossref]

73- Pigareva V, Gorbunova E, Dubinina T, Grozdova I, Melik‐Nubarov N, Simonenko E, Sybachin A. Adsorption of Carboxymethylcyclodextrins on Cationic Liposomes as a Route for Preparation of Capacious Nanocontainers for the Hydrophobic Molecules. Macromolecular Symposia. 2024;413(3) [Crossref]

74- Bonfield T, Zuckerman S, Sutton M, Korley J, von Recum H. Polymerized cyclodextrin microparticles for sustained antibiotic delivery in lung infections. J Biomedical Materials Res. 2024;112(8):1305 [Crossref]

75- Carvalho R, Rosa I, Gomes D, Goliatt P, Goliatt L. Gaussian processes regression for cyclodextrin host-guest binding prediction. J Incl Phenom Macrocycl Chem. 2021;101(1-2):149 [Crossref]

76- Alghamdi W, Alterary S, Alarifi A, Ramu R, Khan M, Afzal M. Exploring the interaction of curcumin with β-cyclodextrin and its binding with DNA: A combined spectroscopic and molecular docking study. International Journal of Biological Macromolecules. 2024;282:137238 [Crossref]

77- Kumar V, Sharma N, Janghu P, Pasrija R, Umesh M, Chakraborty P, Sarojini S, Thomas J. Synthesis and characterization of chitosan nanofibers for wound healing and drug delivery application. Journal of Drug Delivery Science and Technology. 2023;87:104858 [Crossref]

78- Lima Cavalcanti I, Xavier Junior F, Santos Magalhães N, Lira Nogueira M. Isothermal titration calorimetry (ITC) as a promising tool in pharmaceutical nanotechnology. International Journal of Pharmaceutics. 2023;641:123063 [Crossref]

79- Ricci F, Racaniello G, Lopedota A, Laquintana V, Arduino I, Lopalco A, Cutrignelli A, Franco M, Sigurdsson H, Denora N. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery. International Journal of Pharmaceutics. 2022;622:121905 [Crossref]

80- Zhang K, Ren X, Chen J, Wang C, He S, Chen X, Xiong T, Su J, Wang S, Zhu W, Zhang J, Wu L. Particle Design and Inhalation Delivery of Iodine for Upper Respiratory Tract Infection Therapy. AAPS PharmSciTech. 2022;23(6) [Crossref]

81- Guleria A, Gandhi V, Kunwar A, Debnath A, Adhikari S. Highly stable spherical shaped and blue photoluminescent cyclodextrin-coated tellurium nanocomposites prepared by in situ generated solvated electrons: a rapid green method and mechanistic and anticancer studies. Dalton Trans. 2022;51(16):6366 [Crossref]

82- Abdellatif A, Ahmed F, Mohammed A, Alsharidah M, Al-Subaiyel A, Samman W, Alhaddad A, Al-Mijalli S, Amin M, Barakat H, Osman S. Recent Advances in the Pharmaceutical and Biomedical Applications of Cyclodextrin-Capped Gold Nanoparticles. IJN. 2023;Volume 18:3247 [Crossref]

83- Majumder S, Eckersall P, George S. Bovine Mastitis: Examining Factors Contributing to Treatment Failure and Prospects of Nano-enabled Antibacterial Combination Therapy. ACS Agric Sci Technol. 2023;3(7):562 [Crossref]

84- Alboabdullah A, Goodarzi M, Homayouni Tabrizi M. The Lawson-loaded β-cyclodextrin nanocarriers (LB-NCs) a novel targeted cancer cell in stomach and breast cancer as a drug delivery system. Naunyn-Schmiedeberg's Arch Pharmacol. 2024;397(9):6623 [Crossref]

85- Elbagory A, Marima R, Dlamini Z. Role and Merits of Green Based Nanocarriers in Cancer Treatment. Cancers. 2021;13(22):5686 [Crossref]

86- Yousuf S, Alexander A, Sumohan Pillai A, Enoch I. Interaction of Atorvastatin-loaded magnetic iron oxide nanoparticles with DNA. Inorganic and Nano-Metal Chemistry. 2023;:1 [Crossref]

87- Hidayat M, Fitrayani N, Alik Samma A, Anggriani A, Permana A. Validation of spectrophotometric and colorimetric methods for determination of efavirenz in various biological matrices: Application to the development of dissolvable microneedle-based efavirenz complex inclusion for vaginal delivery. Microchemical Journal. 2024;200:110361 [Crossref]

88- Khan M, Khan S, Kazi M, Alshehri S, Shahid M, Khan S, Hussain Z, Sohail M, Shafique M, Hamid H, Kamran M, Elhissi A, Wasim M, Thu H. Norfloxacin Loaded Lipid Polymer Hybrid Nanoparticles for Oral Administration: Fabrication, Characterization, In Silico Modelling and Toxicity Evaluation. Pharmaceutics. 2021;13(10):1632 [Crossref]

89- Sybachin A, Pigareva V. Ensembles of carboxymethyl cyclodextrins on cationic liposomes as highly efficient nanocontainers for the delivery of hydrophobic compounds. Biochimica et Biophysica Acta (BBA) - General Subjects. 2023;1867(6):130363 [Crossref]

90- Quintana-Contardo S, Donoso-González O, Lang E, Guerrero A, Noyong M, Simon U, Kogan M, Yutronic N, Sierpe R. Optimizing Dacarbazine Therapy: Design of a Laser-Triggered Delivery System Based on β-Cyclodextrin and Plasmonic Gold Nanoparticles. Pharmaceutics. 2023;15(2):458 [Crossref]

91- Mazyed E, Badria F, ElNaggar M, El-Masry S, Helmy S. Development of Cyclodextrin-Functionalized Transethoniosomes of 6-Gingerol: Statistical Optimization, In Vitro Characterization and Assessment of Cytotoxic and Anti-Inflammatory Effects. Pharmaceutics. 2022;14(6):1170 [Crossref]